Harnessing RNAi for the Development of Complement Therapeutics
Time: 1:30 pm
day: Conference Day Two
Details:
- Mechanism and properties of Alynlam’s RNA interference drugs
- Applications of Cemdisiran, a C5 targeting siRNA
- Exploring RNAi for other complement pathway targets
